Literature DB >> 30657459

Melatonin reduced endometrial hyperplasia induced by estradiol in female albino rats.

Heba A Abdel-Hamid1, Nagwa M Zenhom, Nisreen Dm Toni.   

Abstract

Melatonin, the pineal gland hormone, plays a crucial role in regulation of neuroendocrine and defensive functions, free radicals neutralization, and suppresses angiogenesis, proliferation and cancer. The purpose of designing our study is to assess the effect of estradiol benzoate and its combination with melatonin on uteri of female albino rats. For 4 weeks, the present study was conducted on thirty six female rats separated into 3 groups: Control group (rats received the vehicle), EB group (rats were treated by estradiol benzoate (600 μg/kg intramuscular) for induction of endometrial hyperplasia), and EB+Mel group (rats were treated with estradiol benzoate (600 μg/kg) plus melatonin (50 µg/ml) added to drinking water. Melatonin administration reduced estradiol benzoate-induced endometrial hyperplasia and prevented the occurrence of atypia associated with a significant reduction in lipid peroxide level and NF-κB mRNA and a significant rise in immune-expression of caspase-3, interleukin-2 (IL-2) mRNA and total antioxidant levels in uterine tissues. The results demonstrated that melatonin reduced estradiol benzoate action on the endometrium.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657459     DOI: 10.4149/gpb_2018035

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  2 in total

1.  The role of TNFTNFα/p53 pathway in endometrial cancer mouse model administered with apple seed extract.

Authors:  Sang-Hwan Kim
Journal:  Histol Histopathol       Date:  2021-11-05       Impact factor: 2.303

2.  Piceatannol SNEDDS Attenuates Estradiol-Induced Endometrial Hyperplasia in Rats by Modulation of NF-κB and Nrf2/HO-1 Axes.

Authors:  Lenah S Binmahfouz; Basma G Eid; Amina M Bagher; Rasheed A Shaik; Najlaa S Binmahfouz; Ashraf B Abdel-Naim
Journal:  Nutrients       Date:  2022-04-30       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.